Welcome to the Kids' Library!

Opioid Review Modernization Act of 2016 : report (to accompany H.R. 4976) (including cost estimate o

United States. Congress. House. Committee on Energy and Commerce, author.
[Washington, D.C.] : [U.S. Government Publishing Office], [2016] 2016

PDUFA V medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Co

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2012. 2012

Perspectives of drug manufacturers : abbreviated new drug applications.

United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990. 1990

Perspectives of drug manufacturers : investigational new drug and new drug applications.

United States. Department of Health and Human Services. Office of Inspector General. Office of Evaluation and Inspections, author.
[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, Office of Evaluation and Inspections, 1990. 1990

Review of the proposed generic drug and biosimilars user fees and further examination of drug shorta

United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Washington : U.S. Government Printing Office, 2013. 2013

RU-486 : demonstrating a low standard for women's health? : hearing before the Subcommittee on Crimi

United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources.
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007. 2007